Globally, about 26 million people die every year in severe pain and of which, one in ten is a child. The deaths could be easily alleviated with morphine at just three cents per dose, reveals a new study.
Approximately, half of all deaths that occur every year. The findings are reported in The Lancetmedical journal, warning of a "global pain crisis."
The vast majority of the world's population (75%) live in countries that provide less than half of the morphine needed for palliative care.
About 61 million people suffer from severe physical and psychological problems and pain every year, worldwide.
Of which, 83 percent people live in low and middle-income countries, and access to low-cost, off-patent morphine is rare or unavailable.
The annual burden, when numbered in days of severe physical and psychological suffering, is enormous.
Nearly, six billion days which accounts for 80 percent in the low and middle-income countries, revealed The Lancet Commission on Global Access to Palliative Care and Pain Relief, where the team studied the health issue for three years.
Globally, only about 10.8 metric tonnes of oral morphine is distributed to low and middle-income countries out of 298.5 metric tonnes.
Felicia Knaul, chair of The Lancet Commission and Professor at the Leonard M. Miller School of Medicine at the University of Miami quoted, "The pain gap is a massive global health emergency which has been ignored, except in rich countries."
The oral and injectable morphine can be immediately released at the center of the essential package.
A pain-relieving dose in high-income countries, costs about three cents per 10 mg. Whereas, in the low-income countries, it costs about 16 cents when it is available.
"The pain gap is a double-edged sword with too little access to inexpensive opioids for developing nations and misuse by the rich ones. The enormous disparity between need and availability of opioids for palliative care is growing and skewed against people living in poverty," said Julio Frenk, co-author, and President of the University of Miami.
Pain reliever opioid resembles opium in its addictive properties and physiological effects.
Nearly, 172 countries have been studied. Of which, 25 countries had no morphine essentially, and 15 countries had enough to meet less than one percent of pain relief requirements.